
Clinigence Holdings ( ($NUTX) ) has issued an announcement. On November 16, 2026, Nutex Health’s board, acting unanimously through its four independent directors while three non-independent directors recused themselves, declared
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| NUTX | Clinigence Holdings | 162.64 | 25.72 | 18.78% |
| Name | Price | % Change | |
|---|---|---|---|
| $162.64 | +18.78% |

Clinigence Holdings ( ($NUTX) ) has issued an announcement. On November 16, 2026, Nutex Health’s board, acting unanimously through its four independent directors while three non-independent directors recused themselves, declared

Nutex Health (NUTX) announced that its board, acting by unanimous approval of its independent directors, has declared a special cash dividend of $2.00 per share of the company’s common stock,

Clinigence Holdings Inc (($NUTX)) has held its Q3 earnings call. Read on for the main highlights of the call. Nutex Holdings delivered a broadly positive earnings call, led by stronger

B. Riley raised the firm’s price target on Nutex Health (NUTX) to $357 from $325 and keeps a Buy rating on the shares. Nutex Health beat Q3 earnings expectations on

Lake Street raised the firm’s price target on Nutex Health (NUTX) to $333 from $310 and keeps a Buy rating on the shares. Q3 was Nutex’s “cleanest quarter in years

Reports Q3 revenue $217.6M, consensus $214.82M. “2026 is continuing to be a solid financial year, including total revenue of $644.9M, net income attributable to Nutex of $152.9M, diluted EPS of

Ladenburg initiated coverage of Nutex Health (NUTX) with a Buy rating and $336 price target Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try

Freedom Capital raised the firm’s price target on Nutex Health (NUTX) to $306 from $280 and keeps a Buy rating on the shares after hosting management for investor meetings with

Nutex Health (NUTX) announced that it has received approval to dual-list its common stock on Nasdaq Texas. Trading on the Nasdaq Texas venue is expected to commence at the market

B. Riley raised the firm’s price target on Nutex Health (NUTX) to $325 from $290 and keeps a Buy rating on the shares as the firm transferred coverage of the
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Mar 4, 2027TBA | $1.11B | $5.87 | $226.26M | 1.68 | 6.83 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.